niacinamide has been researched along with phenylephrine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hamaguchi, M; Imai, S; Ishibashi, T | 1 |
| Flavahan, NA; Morrison, KJ; Vanhoutte, PM | 1 |
| Brooks, HL; Gross, GJ; Warltier, DC; Wynsen, JC | 1 |
| Kigoshi, S; Muramatsu, I; Nishio, M | 1 |
| Flitney, EW; Hirst, DG; Kennovin, GD; Prise, VE; Tozer, GM | 1 |
| Ando, S; Endo, T; Imaizumi, T; Kubo, T; Shiramoto, M; Tagawa, T; Takeshita, A; Tokunaga, S | 1 |
| Brown, JC; Burns, DM; Dykes, EL; Flitney, FW; Hirst, DG; Kennovin, GD; Ruddock, MW | 1 |
| Allen, JM; Burns, DM; Hirst, DG; Kennovin, GD; Ruddock, MW; Walker, MD | 1 |
| Burns, DM; Hirst, DG; Keane, PF; McKeown, SR; Murphy, L; Ruddock, MW; Walsh, IK | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T; Wakabayashi, K | 1 |
| Hirst, DG; Ruddock, MW | 1 |
| Kerry, Z; Ozer, A; Reel, B; Sevin, G; Yasa, M; Yetik Anacak, G | 1 |
| Demiryürek, AT; Turan, NN | 1 |
| Janković, G; Kostić-Rajačić, S; Rizvić, E; Savić, MM | 1 |
| Ahmed, A; Bova, S; Fusi, F; Gentile, M; Lupetti, P; Paccagnini, E; Panti, A; Spiga, O; Trezza, A | 1 |
16 other study(ies) available for niacinamide and phenylephrine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
2-Nicotinamidoethyl acetate (SG-209) is a potassium channel opener: structure activity relationship among nicorandil derivatives.
Topics: Animals; Cyclic GMP; Glyburide; Male; Methylene Blue; Niacinamide; Nicorandil; Phenylephrine; Potassium Channels; Rabbits; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 1991 |
Differential effects of the antianginal drug nicorandil on canine arteries and veins.
Topics: Adrenergic alpha-Agonists; Animals; Arteries; Azepines; Dinoprost; Dogs; Drug Interactions; Endothelium, Vascular; Female; In Vitro Techniques; Male; Muscle Contraction; Niacinamide; Nicorandil; Norepinephrine; Phenylephrine; Sympathetic Nervous System; Synaptic Transmission; Vasodilator Agents; Veins | 1990 |
Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Dogs; Female; Hemodynamics; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Phenylephrine; Vasodilator Agents | 1987 |
Mechanisms of tetraethylammonium-induced contraction in the canine coronary artery.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Calcium; Cesium; Chlorides; Coronary Vessels; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Phenylephrine; Potassium; Tetraethylammonium Compounds; Vasodilator Agents; Verapamil | 1986 |
The modification of blood flow in tumours and their supplying arteries by nicotinamide.
Topics: Adenocarcinoma; Animals; Arteries; Dose-Response Relationship, Drug; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Perfusion; Phenylephrine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vasoconstriction; Vasodilation | 1995 |
Effects of a novel dihydropyridine calcium antagonist on venous capacitance in Wistar-Kyoto rats.
Topics: Animals; Blood Pressure; Blood Volume; Calcium Channel Blockers; Drug Interactions; Ethanol; Hemodynamics; Hexamethonium Compounds; Male; Niacinamide; Nifedipine; Nitroglycerin; Phenylephrine; Rats; Rats, Inbred WKY; Sympathectomy, Chemical; Vascular Resistance | 1994 |
The effect of the vasodilator nicotinamide on cyclic nucleotide pathways in vascular smooth muscle.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arteries; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Imines; In Vitro Techniques; Muscle, Smooth, Vascular; Niacinamide; Oxadiazoles; Phenylephrine; Phosphoric Diester Hydrolases; Quinoxalines; Rats; Rats, Wistar; Second Messenger Systems; Vasodilation; Vasodilator Agents | 1997 |
Nicotinamide-inhibited vasoconstriction: lack of dependence on agonist signalling pathways.
Topics: Animals; Arginine Vasopressin; Calcium Signaling; Drug Interactions; Endothelium; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Perfusion; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide.
Topics: Adrenergic alpha-Agonists; Arteries; Blood Flow Velocity; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Niacinamide; Phenylephrine; Vasoconstriction | 2000 |
Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Biological Factors; Chlorides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hyperglycemia; Indomethacin; Insulin; Isotonic Solutions; Male; Mesenteric Artery, Superior; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nitric Oxide; Nitroarginine; Nitroprusside; Norepinephrine; Phenylephrine; Potassium; Rats; Rats, Wistar; Sodium | 2004 |
Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Calmodulin; Chickens; Dose-Response Relationship, Drug; Male; Models, Biological; Muscle Contraction; Muscle, Smooth, Vascular; Myosin-Light-Chain Kinase; Niacinamide; Oxygen; Peptides; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Signal Transduction; Time Factors | 2004 |
Diverse effects of calcium channel blockers in the collar model.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Carotid Artery, Common; Endothelium, Vascular; Female; Histamine Agents; Male; Models, Animal; Models, Cardiovascular; Niacinamide; Nifedipine; Phenylephrine; Potassium Chloride; Rabbits; Serotonin; Serotonin Agents; Tunica Intima; Vasodilation; Vasodilator Agents | 2005 |
Preconditioning effects of peroxynitrite in the rat lung.
Topics: Animals; Benzamides; Enzyme Inhibitors; In Vitro Techniques; Ischemic Preconditioning; Lung; Male; Malondialdehyde; Niacinamide; Peroxynitrous Acid; Phenylephrine; Poly(ADP-ribose) Polymerase Inhibitors; Potassium Chloride; Rats; Rats, Wistar; Reperfusion Injury; Uric Acid | 2006 |
Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors.
Topics: Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Phenylephrine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Sympathomimetics; Vasoconstrictor Agents | 2017 |
Dynamin-independent Ca
Topics: Animals; Caffeine; Dynamins; Mitochondrial Dynamics; Niacinamide; Phenylephrine; Rats | 2023 |